Monoclonal Antibody Targeting a Conserved N-Terminal Epitope on 2Apro of Enteroviruses

Kai Yi1,2, Lilan Xie1,2, Yaoming Li1,2

  • 1Hubei Engineering Research Center of Viral Vector, Applied Biotechnology Research Center, Wuhan University of Bioengineering, Wuhan, China.

Insights

Researchers developed a new monoclonal antibody (mAb) targeting enterovirus (EV) protease 2Apro. This antibody aids in identifying hand, foot, and mouth disease pathogens and understanding disease mechanisms.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Enteroviruses (EVs) from species A and B are common causes of hand, foot, and mouth disease (HFMD) in children.
  • The viral protease 2Apro is a conserved protein across EV species, making it a potential target for diagnostics.

Purpose of the Study:

  • To develop a monoclonal antibody (mAb) against the conserved enterovirus protease 2Apro.
  • To evaluate the utility of this mAb in identifying HFMD-associated pathogens.

Main Methods:

  • Hybridoma technique was used to generate a murine mAb, designated 5A3.
  • Indirect fluorescent assay and Western blotting were employed to assess mAb reactivity.
  • Overlapping peptide-based ELISA was utilized to define the epitope recognized by the mAb.

Main Results:

  • The mAb 5A3 was successfully generated and specifically targets EVA71 2Apro.
  • mAb 5A3 demonstrated cross-reactivity with 2Apro from both Enterovirus species A and B.
  • A conserved N-terminal epitope on 2Apro was identified as the target of mAb 5A3.

Conclusions:

  • The developed mAb 5A3 is a valuable tool for identifying enteroviruses causing HFMD.
  • This mAb can aid in elucidating the pathological mechanisms of HFMD.
  • Targeting conserved viral proteins like 2Apro offers a promising strategy for diagnostic development.